Regulatory Focus™ > News Articles > Report: Regulations Banning Industry Gifts in India Still Taking Shape

Report: Regulations Banning Industry Gifts in India Still Taking Shape

Posted 11 April 2012 | By Alexander Gaffney, RAC 

A set of long-awaited pharmaceutical marketing rules preventing companies operating in India from providing free products to doctors in order to drive sales has failed to take shape a year after the regulations were first proposed, reports The Economic Times of India.

"More important policy matters such as drug pricing have taken precedence, pushing the marketing policy to the back seat," a source told The Times, adding it is still in early development stages.

The move follows ones made across the globe, including the US, where the Physician Sunshine Payments Act was bundled into the Patient Protection and Affordable Care Act in 2010.

While some companies preempted that law by voluntarily disclosing their payments to physicians, The Times notes no companies-international or local-have taken such steps in India.

The proposed regulations would ban gifts, sponsored trips, cash payments or any number of other transfers of value to physicians or their families, reports The Times.


Read more:

The Economic Times of India - Drug marketing policy in limbo even after a year


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe